Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 810 of 1,261

  1. US 8748573

    Formulations comprising linaclotide

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  2. US 8748597

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  3. US 8748608

    4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  4. US 8748601

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  5. US 8748607

    Imidazopyrizine syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  6. US 8748625

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  7. US 8748612

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  8. US 8748633

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  9. US 8748621

    1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  10. US 8748648

    Oligomer-calcium channel blocker conjugates

    Nektar Therapeutics · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  11. US 8748176

    Generation of choroid plexus epithelial cells from human embryonic stem cells

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  12. US 8748385

    Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  13. US 8748657

    Process to prepare treprostinil

    United Therapeutics Corporation · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  14. US 8748390

    Immunogenic epitopes of NGEP antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  15. US 8748396

    Lyophilization of synthetic liposomal pulmonary surfactant

    Discovery Laboratories, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  16. US 8748397

    Lyophilization of synthetic liposomal pulmonary surfactant

    Discovery Laboratories, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  17. US 8747843

    Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor

    The Board of Regents of the University of Texas System · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  18. US 8747823

    Compositions and methods for treating a keratin based substrate

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  19. US 8748114

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  20. US 8747919

    Pharmaceutical composition and method of preparing same

    SAISEI MIRAI CLINIC · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  21. US 8747883

    Medical item for long term drug release

    Princeton Trade & Technology, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  22. US 8747872

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  23. US 8747845

    Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  24. US 8747863

    Vaccine for shigella

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.